See more : Solaris Resources Inc. (SLSR) Income Statement Analysis – Financial Results
Complete financial analysis of Yooma Wellness Inc. (LVVEF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yooma Wellness Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Ningbo Zhongbai Co., Ltd. (600857.SS) Income Statement Analysis – Financial Results
- Mithra Pharmaceuticals SA (MITPF) Income Statement Analysis – Financial Results
- Local Bounti Corporation (LOCL) Income Statement Analysis – Financial Results
- Corona Corporation (5909.T) Income Statement Analysis – Financial Results
- A. H. Belo Corporation (AHC) Income Statement Analysis – Financial Results
Yooma Wellness Inc. (LVVEF)
About Yooma Wellness Inc.
Yooma Wellness Inc. engages in the manufacturing, marketing, distribution, and sale of wellness products in Canada, the United States, Europe, and Asia. Its wellness products include hemp seed oil, and hemp-derived and cannabinoid (CBD) ingredients. The company sells its products through various platforms, such as ecommerce, mass-market retail, and independent retail partners. Yooma Wellness Inc. is headquartered in Toronto, Canada.
Metric | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|
Revenue | 0.00 | 10.18M | 34.79K | 152.01K |
Cost of Revenue | 0.00 | 7.81M | 292.50K | 263.71K |
Gross Profit | 0.00 | 2.37M | -257.71K | -111.70K |
Gross Profit Ratio | 0.00% | 23.30% | -740.67% | -73.48% |
Research & Development | 0.00 | 8.70K | 0.00 | 0.00 |
General & Administrative | 0.00 | 11.51M | 2.18M | 2.91M |
Selling & Marketing | 0.00 | 2.11M | 23.28K | 79.87K |
SG&A | 0.00 | 13.62M | 2.20M | 2.99M |
Other Expenses | 0.00 | 912.46K | 0.00 | 7.24K |
Operating Expenses | 0.00 | 14.55M | 2.20M | 2.99M |
Cost & Expenses | 0.00 | 22.36M | 2.50M | 3.26M |
Interest Income | 0.00 | 0.00 | 44.37K | 151.97K |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 170.28K | 912.46K | 13.60K | 7.24K |
EBITDA | 0.00 | 10.05M | -1.74M | 1.90M |
EBITDA Ratio | 0.00% | 98.67% | -3,300.79% | 1,248.31% |
Operating Income | 0.00 | 9.14M | -1.15M | 1.89M |
Operating Income Ratio | 0.00% | 89.71% | -3,300.79% | 1,243.55% |
Total Other Income/Expenses | 0.00 | -33.33M | -1.78M | -8.10M |
Income Before Tax | 0.00 | -33.33M | -3.78M | -8.10M |
Income Before Tax Ratio | 0.00% | -327.28% | -10,850.39% | -5,330.66% |
Income Tax Expense | 0.00 | -214.90K | 1.31M | 5.20M |
Net Income | 0.00 | -33.12M | -5.09M | -13.30M |
Net Income Ratio | 0.00% | -325.17% | -14,625.18% | -8,752.00% |
EPS | 0.00 | -0.43 | -0.73 | -1.92 |
EPS Diluted | 0.00 | -0.43 | -0.73 | -1.92 |
Weighted Avg Shares Out | 0.00 | 77.55M | 6.98M | 6.91M |
Weighted Avg Shares Out (Dil) | 0.00 | 77.55M | 6.98M | 6.91M |
Yooma Wellness snaps up UK market leader Vitality CBD for up to £10.2mln
SEED Innovations invests further £220,000 in Yooma Wellness
SEED Innovations hails funding round by investee Yooma Wellness
Yooma to Cease Operations in China Due to New CBD Regulations
FastForward investee Yooma Wellness plans dual listing in London
Yooma Wellness Announces Pursuit of Dual-Listing on AQSE Growth Market in the UK and Concurrent Financing to Fund Three Accretive Acquisitions
Yooma Wellness Announces Option and Deferred Share Unit Grants to Key Personnel
Source: https://incomestatements.info
Category: Stock Reports